Insights

Strategic Partnership Covaris is a PerkinElmer company with a strategic partnership history including a 2025 collaboration with Hamilton Company to co-market the truXTRAC FFPE SMART Solution. Sales opportunities exist in co-selling through automation-enabled workflows and integrated sample prep solutions for FFPE tissues.

Expansion via truCOLLECT The launch of the truCOLLECT Solution in April 2026 signals growth in pre-analytical collection and processing capabilities. Target opportunities include laboratories seeking end-to-end sample collection and preparation enhancements to improve throughput and data quality.

Clinical Omics Focus Covaris targets multiomics research and clinical applications with Adaptive Focused Acoustics technology. There is potential to cross-sell instruments, consumables, and kits to biopharma and academic labs pursuing precision pre-analytical workflows and reproducible omics data.

Security and Compliance Past data breach incidents underscore the importance of robust data security and privacy measures. A sales approach can emphasize enhanced security features, compliance readiness, and support for customers with stringent data governance requirements.

Automation and Workflows Recent launches include automatable workflow solutions and partnerships leveraging automated liquid handling. Opportunities exist to sell automation-ready interfaces, compatible consumables, and turnkey workflows that reduce manual steps and increase throughput for FFPE and other sample types.

Similar companies to Covaris

Covaris Tech Stack

Covaris uses 8 technology products and services including Hotjar, Amazon Web Services, Jenkins, and more. Explore Covaris's tech stack below.

Media & News

Covaris's Email Address Formats

Covaris uses at least 5 email formats:
Covaris Email FormatsExamplePercentage
FLast@covaris.comJDoe@covaris.com
99%
FMiddleLast@covaris.comJMichaelDoe@covaris.com
1%
FLast@covarisinc.comJDoe@covarisinc.com
80%
Last@covarisinc.comDoe@covarisinc.com
19%
FirstL@covarisinc.comJohnD@covarisinc.com
1%

Frequently Asked Questions

What is Covaris's official website and social media links?

Minus sign iconPlus sign icon
Covaris's official website is covaris.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Covaris generate?

Minus sign iconPlus sign icon
As of August 2026, Covaris's annual revenue is estimated to be $50M - $100M.

What is Covaris's SIC code and NAICS code?

Minus sign iconPlus sign icon
Covaris's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Covaris have currently?

Minus sign iconPlus sign icon
As of August 2026, Covaris has approximately 147 employees across 5 continents, including North America, Europe and Oceania. Key team members include Chief Executive Officer: J. L., Director, Eu Sales: O. S. and Director Of Sales Marketing And Support (fas): S. M. Explore Covaris's employee directory with LeadIQ.

What industry does Covaris belong to?

Minus sign iconPlus sign icon
Covaris operates in the Biotechnology Research industry.

What technology does Covaris use?

Minus sign iconPlus sign icon
Covaris's tech stack includes Hotjar, Amazon Web Services, Jenkins, Hyperion, SAP, Microsoft 365, HubSpot and Piwik PRO Core.

What is Covaris's email format?

Minus sign iconPlus sign icon
Covaris's email format typically follows the pattern of FLast@covaris.com. Find more Covaris email formats with LeadIQ.

How much funding has Covaris raised to date?

Minus sign iconPlus sign icon
As of August 2026, Covaris has raised $882K in funding. The last funding round occurred on Mar 04, 2016 for $732K.
Covaris logo

Covaris

Biotechnology ResearchMassachusetts, United States51-200 Employees

Covaris is a mid-sized biotechnology company based in Woburn, Massachusetts, focused on sample preparation for multiomics research and clinical applications. Since its acquisition by PerkinElmer in 2023, it operates within the PerkinElmer portfolio and offers a range of instruments, consumables, reagents, and kits used in pre-analytical sample processing. The company emphasizes accuracy and reproducibility to help researchers generate high-quality data and support assay development. Its customer base includes academic laboratories as well as global biopharma organizations. In April 2026, Covaris introduced the truCOLLECT Solution, reflecting ongoing product development in its field.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $882K

    Covaris has raised a total of $882K of funding over 2 rounds. Their latest funding round was raised on Mar 04, 2016 in the amount of $732K as a Grant.

  • $50M - $100M

    Covaris's revenue is estimated to be in the range of $50M - $100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.